Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy.

Saved in:
Bibliographic Details
Title: Cardiac Safety of Reduced Cardiotoxicity Surveillance During HER2-Targeted Therapy.
Authors: Yu AF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA. Electronic address: yua3@mskcc.org., Dang CT; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Moskowitz CS; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Mishra Meza A; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., DeFusco P; Hartford Healthcare, Hartford, Connecticut, USA., Oligino E; Hartford Healthcare, Hartford, Connecticut, USA., Chen CL; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Sanford R; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Drullinsky P; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Bromberg J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Wong S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Modi S; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Jorgensen J; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Oeffinger KC; Duke Cancer Institute, Durham, North Carolina, USA., Steingart RM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA., Liu JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA; Department of Medicine, Weill Cornell Medical College, New York, New York, USA. Electronic address: https://twitter.com/JLiu_MSKCardOn.
Source: JACC. CardioOncology [JACC CardioOncol] 2025 Jun; Vol. 7 (4), pp. 430-441.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101761697 Publication Model: Print Cited Medium: Internet ISSN: 2666-0873 (Electronic) Linking ISSN: 26660873 NLM ISO Abbreviation: JACC CardioOncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-0873
DOI:10.1016/j.jaccao.2025.05.006